Clear Harbor Asset Management, LLC Bei Gene, Ltd. Transaction History
Clear Harbor Asset Management, LLC
- $1.22 Billion
- Q3 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 1,571 shares of BGNE stock, worth $276,291. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,571
Previous 1,571
-0.0%
Holding current value
$276,291
Previous $224,000
57.14%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.86 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.13 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$910 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$875 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$652 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $18.2B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...